Argenica Therapeutics LtdASX: AGN

Argenica Therapeutics: Notice of Annual General Meeting/Proxy Form

· Issued by Argenica Therapeutics Ltd via ASX

Filed with ASX · · 23 pages · English

Summary by 6ix AI

The notice includes details on voting procedures, including proxy voting options for shareholders. Shareholders will consider several resolutions, including the adoption of the remuneration report and the re-election of a director. The filing also outlines voting prohibitions and exclusions related to certain resolutions.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/notice-of-annual-general-meetingproxy-form-207

Release

ASX ANNOUNCEMENT NOTICE OF ANNUAL GENERAL MEETING Perth, Australia; 20 OCTOBER 2026 – Argenica Therapeutics Limited (ASX: AGN) (“Argenica” or the “Company”) advises of the following documents in relation to the upcoming Annual General Meeting: - Shareholder Access Letter - Notice of...

Argenica Therapeutics Ltd on 6ix

Earlier from Argenica Therapeutics

Later from Argenica Therapeutics

All Argenica Therapeutics news releases